Obsidian Therapeutics, Inc.

Obsidian Therapeutics is using its proprietary cytoDRiVE platform to harness the power of proteins to engineer precision medicines. Our lead internal programs are focused on engineering TIL therapies that are more effective and safer for patients with solid tumors. At Obsidian, we are pioneering engineered cell and gene therapies to deliver transformative outcomes for patients.